Table of Contents

JUNE 2021 ISSUE

FREE ACCESS: Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial
FREE ACCESS: The Pathway of Belzutifan, from clinical trials to clinical practice:
FREE ACCESS: The Current and Evolving Therapeutic Paradigm in the Management of Metastatic Renal Cell Carcinoma
FREE ACCESS: EXPERT PERSPECTIVES - Nicholas J. Vogelzang, MD, FASCO, FACP
FREE ACCESS: EDITOR'S MEMO
FREE ACCESS: KCJ Journal Club
FREE ACCESS: MEDICAL INTELLIGENCE

JUNE 2021 ISSUE

FREE ACCESS: Resource-efficient pooled sequencing expands translational impact in solid tumors
FREE ACCESS: ROUNDTABLE: Changes, Challenges and Opportunities in Cancer Care During the COVID-19 Era and Beyond
FREE ACCESS: Renal Cell Carcinoma Associated with Germline Mutations in the Krebs Cycle
FREE ACCESS: Editor's Memo - Robert A. Figlin, MD
FREE ACCESS: KCJ Journal Club
FREE ACCESS: Newsworthy, late-breaking information from Web-based sources, professional societies, and government agencies

ASCO SUPPLEMENT - JUNE 2021

FREE ACCESS: RECOMMENDED ABSTRACTS IN KIDNEY CANCER
FREE ACCESS: Practice Changing Results in RCC come from ASCO21
FREE ACCESS: ASCO21 – Kidney Cancer Highlights
FREE ACCESS: ASCO21 – Key Updates for Kidney Cancer Patients
FREE ACCESS: Novel Strategies in Locally Advanced Kidney Cancer – Highlights from KEYNOTE-564

MARCH 2021 ISSUE

FREE ACCESS: ROUNDTABLE: TKIs Beyond Second-Line Therapy: New Perspectives in Renal Cell Carcinoma Therapeutics
FREE ACCESS: Dissecting the role of lymphadenectomy in the management of renal cell carcinoma
FREE ACCESS: It’s Clear as Day: HIF Signaling is Driving Force of the Clear Cell Morphology
FREE ACCESS: Editor's Memo - Robert A. Figlin, MD
FREE ACCESS: Journal Club
Newsworthy, late-breaking information from Web-based sources, professional societies, and government agencies
FREE ACCESS: Editor's Memo - Robert A. Figlin, MD (Recent)



DECEMBER 2020 ISSUE

FREE ACCESS: Impact of Mycobacterial Infections on Outcomes of Patients with Metastatic Renal Cell Carcinoma
FREE ACCESS: Dissecting the role of lymphadenectomy in the management of renal cell carcinoma
FREE ACCESS: HIF-inhibitors in Renal Cell Carcinomas: A Review of Current Trials
FREE ACCESS: Academic Mentorship: Choosing the Right Research Mentor(s)
KCJ EDITOR’S MEMO
KCJ MEDICAL INTELLIGENCE
KCJ JOURNAL CLUB - ESSENTIAL PEER-REVIEWED READING IN KIDNEY CANCER (FREE ACCESS available soon)